B. Braun Melsungen AG – Strategic SWOT Analysis Review

Date: 2016-01

“B. Braun Melsungen AG – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – GlobalData’s summarization of the company’s business strategy.
– SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.


B. Braun Melsungen AG (B. Braun) is a global health care company. It markets and sells products and services catering to basic healthcare, intensive care units, anesthesia and emergency care sectors. The company also provides solutions for extracorporeal blood treatment and core surgical procedures. The company operates in four business divisions namely, Hospital Care division, which supplies the hospitals with infusion, injection solutions and disposable medical products; Aesculap division, which supplies products and services for all the core processes in surgery; Out Patient Market (OPM) division, which supplies medical products outside the hospital for chronically ill and long term care patients; and B. Braun Avitum division compiles the product and services concerning extra-corporeal blood treatment. It operates in Europe, the Americas, Asia-Pacific, Africa and the Middle East. B. Braun is headquartered in Melsungen, Germany.

B. Braun Melsungen AG Key Recent Developments

May 13, 2015: DuBiotech Welcomes Germany’s B.Braun
Apr 20, 2015: medperts goes international
Mar 27, 2015: B. Braun Group increases sales and earnings
Jan 14, 2015: B. Braun Expands Clinical Nutrition Portfolio
Aug 06, 2013: B. Braun won preliminary injunction against Poly Medicure Ltd.’s (Polymed’s) Spanish distributor Dextromédica S. L. (Dextro Médica)

Reasons to Buy

– Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
– Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
– Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
– Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.”

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample